Načítá se...
Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
The treatment of choice for Stenotrophomonas maltophilia is trimethoprim-sulfamethoxazole (SXT). Fluoroquinolones (FQs) have in vitro activity against S. maltophilia; however, there is limited published information on their effectiveness. The purpose of this study is to compare the effectiveness of...
Uloženo v:
Hlavní autoři: | , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
American Society for Microbiology
2014
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3910778/ https://ncbi.nlm.nih.gov/pubmed/24145530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01324-13 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|